Core Points - Zhejiang Wan'an Technology Co., Ltd. has proposed an employee stock ownership plan (ESOP) for 2025, aiming to enhance employee engagement and align their interests with the company's performance [1][12][20] - The plan allows for a maximum of 80,000 shares to be allocated to employees, representing 0.15% of the company's total share capital, with a purchase price set at 7.43 RMB per share [2][11][16] - The ESOP will be subject to performance-based unlock conditions over three years, with specific revenue and profit growth targets set for 2025 to 2027 [19][21][22] Summary by Sections Employee Participation - The plan will involve up to 60 employees, including 9 directors and senior management, with participation based on their contribution to the company's performance [2][7][12] - Employees must fund their participation through personal resources, and the company will not provide any financial assistance [4][10] Stock Acquisition and Pricing - The stock will be sourced from the company's repurchased shares, with a total of 800,000 shares available for the ESOP [10][11][16] - The purchase price is determined based on the average trading price of the company's shares prior to the announcement, ensuring it is set at a reasonable level [11][12] Performance Assessment - The ESOP includes performance targets for revenue and net profit growth, with specific thresholds for unlocking shares over the three-year period [19][21][22] - The targets are designed to ensure that employee interests are aligned with the company's long-term growth and sustainability [20][22] Management and Governance - The ESOP will be managed by a committee elected by the participants, ensuring transparency and accountability in the management of the plan [26][28] - The plan requires approval from the shareholders' meeting before implementation, with provisions for adjustments based on company performance and market conditions [3][31]

Core Viewpoint - The company has developed a draft for the 2025 Employee Stock Ownership Plan (ESOP) in compliance with relevant laws and regulations, aiming to enhance employee engagement and align interests between employees and shareholders [1][2] Compliance with Regulations - The company confirms that there are no prohibitive circumstances under the relevant guidelines and regulations for implementing the employee stock ownership plan [1] - The content of the employee stock ownership plan aligns with the guidelines and does not harm the interests of the company or its shareholders [1] - The decision-making process for the employee stock ownership plan was legal and effective, with related directors abstaining from voting to avoid conflicts of interest [1] Eligibility and Financial Support - The proposed participants in the employee stock ownership plan meet the eligibility criteria set forth in the relevant guidelines [1] - The company does not plan to provide loans, guarantees, or any other financial assistance to the participants of the employee stock ownership plan [1] Benefits of the Plan - The implementation of the employee stock ownership plan is expected to establish a mechanism for shared interests between employees and shareholders, enhancing employee cohesion and the company's competitiveness [1] - The plan aims to create a community of interests between management and shareholders, improving management efficiency and the responsibility of operators, which is beneficial for the company's sustainable development and strategic goals [1]

Group 1 - The company achieved operating revenue of 1.121 billion yuan and a net profit attributable to shareholders of 368 million yuan in the first half of 2025, representing a year-on-year growth of 17.17% [2][3] - The core business of the company, the power equipment segment, showed steady growth with revenue increasing by 127 million yuan, or 15.29% year-on-year [3] - The international revenue exceeded 200 million yuan, with a growth rate of over 40%, primarily driven by the rapid growth of overseas sales in the CNC equipment business [4] Group 2 - The company’s cash flow situation is stable, with fluctuations in operating cash flow aligning with changes in revenue structure, and there are no signs of cash flow pressure [3] - The company’s power engineering business revenue declined due to project settlement timing, impacting both operating costs and cash flow [3][27] - The CNC equipment business showed good performance in the first half of the year, with revenue growth of approximately 33 million yuan, although its contribution to overall revenue and profit remains low [5] Group 3 - The company is focusing on expanding its overseas market presence, particularly in Europe and Asia, where significant growth has been observed [7][13] - The company has established a factory in Indonesia, which has contributed to noticeable growth in the Indonesian market [14] - The company plans to invest in upgrading facilities to support the CNC equipment business and may consider local investments in markets like Saudi Arabia if sufficient orders are secured [17][36] Group 4 - The company’s strategy emphasizes localizing operations in overseas markets, which has proven effective in driving growth [8][20] - The company has not observed significant changes in transformer demand in overseas markets, indicating stable demand conditions [19] - The company aims to maintain a stable gross margin for its products, despite various influencing factors [35] Group 5 - The company has set ambitious targets for net profit growth over the next three years, although achieving these targets may be challenging [33] - The company’s domestic market performance has shown a 5% year-on-year growth, with stable growth in the grid-related segment [22][24] - The company is cautious about projecting future revenue growth due to the short order delivery cycle and the uncertainty in project timelines [31]

证券研究报告 | 公司动态点评 2025 年 08 月 13 日 塔牌集团（002233.SZ） 量增本降助力业绩高增，回购+高股息展现投资价值 作者 分析师 花 江月 执业证书编号：S1070522100002 | 财务指标 | 2023A | 2024A | 2025E | 2026E | 2027E | | --- | --- | --- | --- | --- | --- | | 营业收入（百万元） | 5,535 | 4,278 | 4,413 | 4,532 | 4,769 | | 增长率 yoy（%） | -8.3 | -22.7 | 3.2 | 2.7 | 5.2 | | 归母净利润（百万元） | 742 | 538 | 676 | 742 | 802 | | 增长率 yoy（%） | 178.5 | -27.5 | 25.7 | 9.7 | 8.1 | | ROE（%） | 6.2 | 4.6 | 5.7 | 6.0 | 6.4 | | EPS 最新摊薄（元） | 0.62 | 0.45 | 0.57 | 0.62 | 0.67 | | P/E（倍） | 13.7 | 18.8 | 15.0 ...

Core Viewpoint - Wuhan Keqian Biological Co., Ltd. plans to sign a cooperative research and development agreement with Huazhong Agricultural University, involving four vaccine projects, with a total payment of 4.9 million RMB [2][4][67]. Group 1: Overview of Related Transactions - The company has obtained cooperation for the development of four projects: "Canine Distemper, Canine Parainfluenza, Canine Adenovirus and Canine Parvovirus Quadrivalent Live Vaccine - Inactivated Canine Coronavirus Vaccine," "Porcine Gata Virus Inactivated Vaccine," "Porcine Proliferative Enteropathy Blocking ELISA Antibody Test Kit," and "NADC30-like Porcine Reproductive and Respiratory Syndrome Live Vaccine (GX2024 Strain)" [2][4][67]. - The total payment to Huazhong Agricultural University for these projects is 4.9 million RMB, with specific allocations of 1.5 million RMB, 2 million RMB, 400,000 RMB, and 1 million RMB for each project respectively [4][67]. - The transaction constitutes a related party transaction but does not qualify as a major asset restructuring under relevant regulations [2][4][67]. Group 2: Necessity and Impact of Related Transactions - The cooperative research aims to enhance the company's product portfolio and market competitiveness, although the success of the projects and their market introduction remain uncertain [67]. - The pricing and process of the transaction comply with legal regulations and do not harm the interests of the company or minority shareholders [67]. Group 3: Approval Procedures for Related Transactions - The board of directors and the supervisory board have approved the agreement, with related directors abstaining from voting [68][69]. - Independent directors have expressed that the agreement will enhance the company's core competitiveness in the biological products sector and that the transaction process is legal and fair [71][72]. Group 4: Research and Development Agreement Details - The agreement includes provisions for the rights and obligations of both parties, including the management of research funds and the ownership of intellectual property generated from the projects [8][37][52]. - The agreement is valid for 10 years, with provisions for extension and termination under certain conditions [20][36][66].

登录新浪财经APP 搜索【信披】查看更多考评等级 本公司及董事会全体成员保证信息披露内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗 漏。 丽珠医药集团股份有限公司（以下简称"公司"或"丽珠集团"）中长期事业合伙人持股计划之第二期员工 持股计划（以下简称"本期持股计划"）锁定期于2025年8月12日届满。根据《关于上市公司实施员工持 股计划试点的指导意见》及《深圳证券交易所上市公司自律监管指引第1号一主板上市公司规范运作》 等相关规定，现将本期持股计划相关情况公告如下： 一、本持股计划的基本情况和锁定期 公司于2022年5月20日召开了公司2021年度股东大会，审议通过了《关于公司〈中长期事业合伙人持股 计划之第二期持股计划（草案）〉及其摘要的议案》等相关议案，于2022年7月8日召开了公司2022年第 一次临时股东大会，审议通过了《关于修订公司〈中长期事业合伙人持股计划之第二期持股计划〉及其 摘要的议案》等相关议案，同意公司实施中长期事业合伙人持股计划之第二期持股计划并授权公司董事 会办理相关事宜。有关详情及进展情况请见公司于2022年5月21日、2022年7月9日及2022年8月11日在巨 潮资讯网 ...

Summary of Key Points Core Viewpoint The report provides a detailed account of the fundraising activities and the usage of raised funds by Guangzhou Jitai Chemical Co., Ltd. It outlines the amounts raised, the specific projects funded, and the management of these funds, ensuring compliance with regulatory requirements. Group 1: Fundraising Overview - The company raised a total of RMB 299,999,988.75 from a non-public offering of A-shares in 2020, with a net amount of RMB 280,999,988.75 after deducting underwriting fees [1][2] - In 2022, the company raised RMB 169,602,361.50 from a targeted issuance of A-shares, with a net amount of RMB 153,436,236.32 after fees [3][4] Group 2: Fund Usage and Balances - As of June 30, 2025, the company had used RMB 272,944,538.92 from the 2020 fundraising, with a remaining balance of RMB 7,449,565.95 [5][6] - For the 2022 fundraising, RMB 153,440,976.79 was utilized, leaving a balance of RMB 81,110.48 as of June 30, 2025 [7][8] Group 3: Fund Management and Compliance - The company has established a fund management system in accordance with relevant laws and regulations, ensuring that funds are stored in dedicated accounts and used for specified projects [9][10] - The company has signed tripartite and quadripartite supervision agreements with banks and underwriters to ensure compliance with fundraising regulations [11][12] Group 4: Project Adjustments and Changes - The company adjusted its project plans based on operational needs and market conditions, including changes to production capacities and project timelines [15][16][17] - The total investment for the adjusted projects was revised from RMB 42,025.89 million to RMB 39,831.01 million, with completion dates extended [17] Group 5: Remaining Funds and Future Plans - As of June 30, 2025, the company has unutilized funds of RMB 744,960.00 from the 2020 fundraising and RMB 81,110.48 from the 2022 fundraising, all stored in dedicated accounts [19][20] - The company plans to use the remaining funds for project completion and operational needs, ensuring efficient use of resources [21][22]

Core Viewpoint - The company has not met the performance assessment indicators for the third unlocking period of its 2022 employee stock ownership plan, resulting in no shares being unlocked for this period [8][12][26]. Group 1: Employee Stock Ownership Plan Approval and Implementation - The employee stock ownership plan was approved by the company's board of directors on August 23, 2022, and subsequently by the shareholders on September 9, 2022 [6][27]. - The plan involves a total of 2,950,060 shares, which were transferred to the employee stock ownership plan at a price of 7.50 yuan per share, accounting for 0.51% of the company's total share capital [29]. Group 2: Locking Period and Performance Assessment - The locking period for the employee stock ownership plan is set for a maximum of 36 months, with shares being unlocked in three phases: 30% after 12 months, 35% after 24 months, and 35% after 36 months [9][30]. - The company’s performance assessment for the third unlocking period was based on company-level and individual-level indicators, which were not met, leading to 1,032,521 shares being locked and not unlocked [11][31]. Group 3: Consequences of Not Meeting Performance Indicators - Due to the failure to meet the performance indicators, the shares will be reclaimed by the management committee of the employee stock ownership plan and may be sold to return the investment amount to the holders [12][31]. - If any profits arise from the sale of the shares, those profits will belong to the company [12][31]. Group 4: Future Considerations - The employee stock ownership plan has a total duration of 48 months, and if not extended, it will terminate upon reaching the end of this period [33]. - The company will continue to monitor the implementation of the employee stock ownership plan and fulfill its disclosure obligations as required by law [35].

Group 1 - The first meeting of the 2025 second employee stock ownership plan was held on August 9, 2025, with 99 participants representing 12,931,462 shares [2][3] - The meeting unanimously approved the establishment of a management committee for the employee stock ownership plan and elected members, ensuring no conflicts of interest with major shareholders or executives [3] - The management committee is authorized to handle various matters related to the employee stock ownership plan until its completion, including convening meetings, exercising shareholder rights, and managing daily operations [4][5] Group 2 - The management committee's responsibilities include decision-making on share transfers, qualification cancellations, and signing relevant agreements on behalf of the plan [5] - All resolutions passed during the meeting received 100% approval from the participating shareholders, indicating strong support for the plan [3][4] - The management committee's chairperson was elected on the same day, with a term lasting until the plan's completion [3]

Core Viewpoint - The company plans to repurchase shares to enhance investor confidence and implement an employee stock ownership plan, with a total repurchase fund not exceeding 100 million yuan and a price cap of 10 yuan per share [1][2][5]. Summary by Sections Repurchase Plan Overview - The repurchase aims to maintain shareholder interests and enhance investor confidence, based on the company's confidence in its future development and value recognition [1][5]. - The repurchased shares will be used for the company's employee stock ownership plan [2]. Details of the Repurchase - The repurchase will involve domestic listed ordinary shares (A shares) and will be conducted through centralized bidding [2]. - The maximum repurchase price is set at 10 yuan per share, which is 150% of the average trading price over the previous 30 trading days before the board's decision [2]. - The total repurchase fund will range from 50 million yuan to 100 million yuan, sourced from the company's own funds [2][5]. - The estimated number of shares to be repurchased is approximately 1 million shares at the upper limit and 500,000 shares at the lower limit, representing 0.84% and 0.42% of the total share capital, respectively [2][5]. Implementation Timeline - The repurchase will occur within six months from the board's approval, with possible extensions if the stock is suspended for more than ten trading days due to major events [3]. - The repurchase will conclude if the maximum fund is used or if the number of repurchased shares reaches 10% of the total issued shares [3]. Impact Analysis - The repurchase is expected to enhance trading activity in the secondary market and boost investor confidence, benefiting all shareholders [5]. - The total assets of the company are projected to be 13.499 billion yuan, with a net profit of 538 million yuan for the year 2024. The maximum repurchase amount would account for 0.74% of total assets and 18.59% of the net profit [5]. - The repurchase is not intended to affect the company's operational capabilities or financial health and aims to support long-term sustainable development [5]. Compliance and Reporting - The company has established a dedicated securities account for the repurchase, ensuring compliance with relevant regulations [8]. - The company will disclose repurchase progress regularly, including any significant changes in shareholding [8].